| Date of Action |
Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|---|---|
| Mar 14, 2024 |
referred to health |
Senate Bill S8807
2023-2024 Legislative Session
Sponsored By
(R) 43rd Senate District
Archive: Last Bill Status - In Senate Committee Health Committee
Actions
co-Sponsors
(D) 34th Senate District
2023-S8807 (ACTIVE) - Details
- Current Committee:
- Senate Health
- Law Section:
- Public Health
- Versions Introduced in 2025-2026 Legislative Session:
-
S4664
2023-S8807 (ACTIVE) - Summary
Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders.
2023-S8807 (ACTIVE) - Sponsor Memo
BILL NUMBER: S8807
SPONSOR: ASHBY
TITLE OF BILL:
An act in relation to to directing the commissioner of health to conduct
a study on the use of ibogaine as a treatment for post-traumatic stress
disorder
PURPOSE OR GENERAL IDEA OF BILL:
To study and provide recommendations on the use of ibogaine to treat
post-traumatic stress disorder, especially among veterans and first
responders.
SUMMARY OF PROVISIONS:
Section 1 authorizes and directs the commissioner of health, in conjunc-
tion with the commissioner of mental health and the commissioner of
veterans' services to conduct a study to research the use of ibogaine to
treat post-traumatic stress disorder, specifically among veterans and
first responders.
2023-S8807 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K
________________________________________________________________________
8807
I N S E N A T E
March 14, 2024
___________
Introduced by Sen. ASHBY -- read twice and ordered printed, and when
printed to be committed to the Committee on Health
AN ACT in relation to to directing the commissioner of health to conduct
a study on the use of ibogaine as a treatment for post-traumatic
stress disorder
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. 1. The commissioner of health, in conjunction with the
commissioner of mental health and the commissioner of veterans'
services, is authorized and directed to conduct a study to research the
use of ibogaine as a treatment for post-traumatic stress disorder and
the increasing rate of diagnoses of post-traumatic stress disorder in
veterans and first responders.
2. The study conducted pursuant to subdivision 1 of this section shall
examine any possible benefits and risks, and the appropriateness and
effectiveness of ibogaine as a treatment for post-traumatic stress
disorder.
3. The commissioner of health shall submit a report on the findings of
the study conducted pursuant to subdivision 1 of this section, and
recommendations, to the governor, the speaker of the assembly, the
temporary president of the senate, the minority leader of the senate,
the minority leader of the assembly and all members of each house of the
New York state legislature no later than one year following the effec-
tive date of this act.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14849-01-4
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.